Holdings
NEA Management Company, LLC
As of Sep 30, 2026, NEA Management Company, LLC reported 23 positions worth US$1.3B. Largest: MBX Biosciences, Inc., SpyGlass Pharma, Inc. and Trevi Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| MBX Biosciences, Inc. | 3.61M | US$212M | no change | Sep 30, 2026 |
| SpyGlass Pharma, Inc. | 7.39M | US$192M | no change | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 13.2M | US$189M | no change | Sep 30, 2026 |
| Celcuity Inc. | 1.71M | US$136M | no change | Sep 30, 2026 |
| Savara, Inc. | 24.5M | US$126M | no change | Sep 30, 2026 |
| Zenas BioPharma, Inc. | 4.02M | US$109M | no change | Sep 30, 2026 |
| Monte Rosa Therapeutics, Inc. | 6.69M | US$79.8M | −1M | Sep 30, 2026 |
| Aurinia Pharmaceuticals Inc | 3.97M | US$64.3M | no change | Sep 30, 2026 |
| Coursera, Inc. | 12.9M | US$63.8M | no change | Sep 30, 2026 |
| ORIC Pharmaceuticals, Inc. | 4.12M | US$55.5M | no change | Sep 30, 2026 |